Filing Details
- Accession Number:
- 0001209191-18-005841
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-29 16:22:56
- Reporting Period:
- 2018-01-25
- Accepted Time:
- 2018-01-29 16:22:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1566044 | Menlo Therapeutics Inc. | MNLO | Pharmaceutical Preparations (2834) | 453757789 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1634632 | L.p. Ii Fund Strategic Global Venbio | 1700 Owens Street Suite 595 San Francisco CA 94158 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-01-25 | 265,000 | $17.00 | 265,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-01-29 | 1,196,552 | $0.00 | 1,461,552 | No | 4 | C | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | C | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Preferred Stock | Disposition | 2018-01-29 | 3,227,700 | $0.00 | 1,196,552 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct |
Footnotes
- Effective immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of the Series C Preferred Stock automatically converted into 0.3707 shares of the Issuer's common stock.